Natalie Mackow is a prominent inventor based in East Setauket, NY (US). She has made significant contributions to the field of virology, particularly in the development of recombinant paramyxoviruses. With a total of three patents to her name, her work has implications for vaccine development against respiratory viruses.

Latest Patents

Mackow's latest patents include innovative technologies such as the recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 F protein. This invention provides a viral genome encoding a heterologous gene, which can be utilized in vaccine formulations. Another notable patent is the recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein. Both patents focus on the potential use of recombinant viruses in vaccines against parainfluenza virus and respiratory syncytial virus.

Career Highlights

Natalie Mackow is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to contribute to important research in the field of infectious diseases.

Collaborations

Mackow has collaborated with notable colleagues such as Peter L. Collins and Bo Liang. These collaborations have further enhanced her research and innovation in the field of virology.

Conclusion

Natalie Mackow's contributions to the field of virology through her patents and research at the National Institutes of Health highlight her role as an influential inventor. Her work continues to pave the way for advancements in vaccine development against critical respiratory viruses.

This text is generated by artificial intelligence and may not be accurate.